Patentees File Claim under 28 U.S.C. § 1498 before Court of Federal Claims, and Federal Government Files Motion to Dismiss under 28 U.S.C. § 1500

In addition to Arbutus Biopharma and Genevant Sciences defending on appeal the District Court’s summary judgment decision in their favor, these plaintiffs filed their complaint against the Federal Government pursuant to 28 U.S.C. § 1498 for recompense before the Court of Federal Claims (No. 26-446 C) resulting from Moderna’s infringing activities relating to patented lipid nanoparticle components of...... By: McDonnell Boehnen Hulbert & Berghoff LLP